[Cl:1][C:2]1[C:11]([C:12](=[O:19])[CH2:13][C:14]([O:16][CH2:17][CH3:18])=[O:15])=[CH:10][C:9]2[C:4](=[CH:5][C:6]([Cl:21])=[C:7]([F:20])[CH:8]=2)[N:3]=1.CO[CH:24](OC)[N:25]([CH3:27])[CH3:26]>C(OCC)(=O)C>[Cl:1][C:2]1[C:11]([C:12]([C:13](=[CH:24][N:25]([CH3:27])[CH3:26])[C:14]([O:16][CH2:17][CH3:18])=[O:15])=[O:19])=[CH:10][C:9]2[C:4](=[CH:5][C:6]([Cl:21])=[C:7]([F:20])[CH:8]=2)[N:3]=1A suspension of ethyl 3-(2,7-dichloro-6-fluoro-3-quinolinyl)-3-oxopropionate (16.5 g) in ethyl acetate (160 cc) and N,N-dimethylformamide dimethyl acetal (19 cc) is heated to a temperature in the region of 75° C. with stirring for 2 hours. The reaction mixture is concentrated to dryness under reduced pressure (20 kPa) at 50° C. The dry extract is taken up with isopropyl ether (50 cc), drained and washed with isopropyl ether (2×10 cc). Ethyl 2-(2,7-dichloro-6-fluoro-3-quinolinecarbonyl)-3-(dimethylamino)acrylate (16.57 g) is obtained in the form of an orange-colored solid, m.p. 122° C. This product is used without further purification for the subsequent steps.